Sparsha Pharma Usa Inc
FDA inspection history in Oceanside, California, 2025
- 1
- Form 483
Every document, by year
- Form 483
2025: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2025One Form 483, at Oceanside, California.
Cited most
Across all Sparsha Pharma Usa observations on file
- 21 CFR 211.160(a)General requirements2
- 21 CFR 8201
- 21 CFR 211.142Warehousing procedures1
- 21 CFR 211.165(e)Testing and release for distribution1
- 21 CFR 211.188(b)(7)Batch production and control records1
The complete Sparsha Pharma Usa file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Oceanside, California
One Form 483 · 2025 · 10 observations
Latest: Form 483, Sep 4, 2025 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2025-09-04 | 483 Form 483 | Oceanside, California | 10 | $99 |
Investigators on these documents
Cecilia H. Kieu (1)Crystal Monroy (1)Joey V. Quitania (1)Katherine E. Jacobitz (1)Navneet Kaur (1)
FEI number 3010888655 · most recent document Sep 4, 2025
About Sparsha Pharma Usa Inc
How many FDA Form 483s has Sparsha Pharma Usa Inc received?
FDA Intel has 1 Form 483 on file for Sparsha Pharma Usa Inc; the most recent is dated Sep 4, 2025.
When was Sparsha Pharma Usa Inc last inspected by FDA?
The most recent FDA inspection document on file for Sparsha Pharma Usa Inc is a Form 483 dated Sep 4, 2025, for the site in Oceanside, California.
What did FDA cite at Sparsha Pharma Usa Inc?
The regulations cited most in the observations on file for Sparsha Pharma Usa Inc are 21 CFR 211.160(a) (General requirements), 2 times; 21 CFR 820, 1 time; 21 CFR 211.142 (Warehousing procedures), 1 time.